Article Text

Download PDFPDF
Contraception choice for HIV positive women
  1. H S Mitchell1,
  2. E Stephens2
  1. 1Mortimer Market Centre, Camden Primary Care Trust, London, UK
  2. 2Margaret Pyke Centre, Camden Primary Care Trust, London, UK
  1. Correspondence to:
 Dr Helen Mitchell
 Depaartment of Sexually Transmitted Diseases, Mortimer Market Centre, Off Capper Street, Camden Primary Care Trust, London WC1E 6AU, UK;


UNAIDS/WHO estimates that 42 million people are living with HIV/AIDS worldwide and 50% of all adults with HIV infection are women predominantly infected via heterosexual transmission. Women with HIV infection, like other women, may wish to plan pregnancy, limit their family, or avoid pregnancy. Health professionals should enable these reproductive choices by counselling and appropriate contraception provision at the time of HIV diagnosis and during follow up. The aim of this article is to present a global overview of contraception choice for women living with HIV infection including effects on sexual transmission risk.

  • contraception
  • HIV
  • women
  • COC, combined contraceptive pill
  • DMPA, depot medroxyprogesterone acetate
  • HAART, highly active antiretroviral therapy
  • IUDs, intrauterine devices
  • LNG-IUS, levonorgestrel intrauterine system
  • NET-EN, norethisterone enanthate
  • NNRTIs, non-nucleotide reverse transcriptase inhibitors
  • PID, pelvic inflammatory disease
  • PIs, protease inhibitors
  • POP, progestogen only pill

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


Linked Articles

  • Brief Encounters
    Helen Ward Rob Miller